These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7987780)

  • 1. The treatment of depression with group behavioural-cognitive therapy and imipramine.
    Stravynski A; Verreault R; Gaudette G; Langlois R; Gagnier S; Larose M
    Can J Psychiatry; 1994 Sep; 39(7):387-90. PubMed ID: 7987780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program.
    Shea MT; Elkin I; Imber SD; Sotsky SM; Watkins JT; Collins JF; Pilkonis PA; Beckham E; Glass DR; Dolan RT
    Arch Gen Psychiatry; 1992 Oct; 49(10):782-7. PubMed ID: 1417430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.
    Sotsky SM; Glass DR; Shea MT; Pilkonis PA; Collins JF; Elkin I; Watkins JT; Imber SD; Leber WR; Moyer J
    Am J Psychiatry; 1991 Aug; 148(8):997-1008. PubMed ID: 1853989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments.
    Elkin I; Shea MT; Watkins JT; Imber SD; Sotsky SM; Collins JF; Glass DR; Pilkonis PA; Leber WR; Docherty JP
    Arch Gen Psychiatry; 1989 Nov; 46(11):971-82; discussion 983. PubMed ID: 2684085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy.
    Foa EB; Kozak MJ; Steketee GS; McCarthy PR
    Br J Clin Psychol; 1992 Sep; 31(3):279-92. PubMed ID: 1393157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential relapse following cognitive therapy and pharmacotherapy for depression.
    Evans MD; Hollon SD; DeRubeis RJ; Piasecki JM; Grove WM; Garvey MJ; Tuason VB
    Arch Gen Psychiatry; 1992 Oct; 49(10):802-8. PubMed ID: 1417433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients.
    Stewart JW; Mercier MA; Agosti V; Guardino M; Quitkin FM
    J Clin Psychopharmacol; 1993 Apr; 13(2):114-9. PubMed ID: 8463443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive therapy and pharmacotherapy for depression. Singly and in combination.
    Hollon SD; DeRubeis RJ; Evans MD; Wiemer MJ; Garvey MJ; Grove WM; Tuason VB
    Arch Gen Psychiatry; 1992 Oct; 49(10):774-81. PubMed ID: 1417429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
    Mercier MA; Stewart JW; Quitkin FM
    J Clin Psychiatry; 1992 May; 53(5):166-70. PubMed ID: 1592844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program.
    Krupnick JL; Sotsky SM; Simmens S; Moyer J; Elkin I; Watkins J; Pilkonis PA
    J Consult Clin Psychol; 1996 Jun; 64(3):532-9. PubMed ID: 8698947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive behavioral group psychotherapy combined with imipramine in major depression.
    Covi L; Lipman RS
    Psychopharmacol Bull; 1987; 23(1):173-6. PubMed ID: 3602315
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of targeting the vulnerability factors of depression in cognitive therapy.
    Hayes AM; Castonguay LG; Goldfried MR
    J Consult Clin Psychol; 1996 Jun; 64(3):623-7. PubMed ID: 8698959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do depressed patients with higher pretreatment stress levels respond better to cognitive therapy than imipramine?
    Garvey MJ; Hollon SD; DeRubeis RJ
    J Affect Disord; 1994 Sep; 32(1):45-50. PubMed ID: 7798466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression, mastery and number of group sessions attended predict outcome of patients with panic and agoraphobia in a behavioural/medication program.
    Bowen R; South M; Fischer D; Looman T
    Can J Psychiatry; 1994 Jun; 39(5):283-8. PubMed ID: 8044744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program.
    Elkin I; Gibbons RD; Shea MT; Sotsky SM; Watkins JT; Pilkonis PA; Hedeker D
    J Consult Clin Psychol; 1995 Oct; 63(5):841-7. PubMed ID: 7593878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine.
    Overall JE; Donachie ND; Faillace LA
    J Clin Psychiatry; 1987 Feb; 48(2):51-4. PubMed ID: 3542984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of depressive symptoms in human immunodeficiency virus-positive patients.
    Markowitz JC; Kocsis JH; Fishman B; Spielman LA; Jacobsberg LB; Frances AJ; Klerman GL; Perry SW
    Arch Gen Psychiatry; 1998 May; 55(5):452-7. PubMed ID: 9596048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal course of change of depression.
    Watkins JT; Leber WR; Imber SD; Collins JF; Elkin I; Pilkonis PA; Sotsky SM; Shea MT; Glass DR
    J Consult Clin Psychol; 1993 Oct; 61(5):858-64. PubMed ID: 8245283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of psychotherapy in non-bipolar depression: a review.
    Balslev Jørgensen M; Dam H; Bolwig TG
    Acta Psychiatr Scand; 1998 Jul; 98(1):1-13. PubMed ID: 9696508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.
    Mitchell JE; Pyle RL; Eckert ED; Hatsukami D; Pomeroy C; Zimmerman R
    Arch Gen Psychiatry; 1990 Feb; 47(2):149-57. PubMed ID: 2405806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.